Skip to Content
You are currently on the new version of our website. Access the old version .
  • Correction
  • Open Access

9 May 2020

Correction: Al-Zamel, N., et al. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019, 20, 3532.

,
,
,
,
,
and
1
Department of Pharmacology & Toxicology, Faculty of Medicine, Kuwait University, PO Box 24923, 13110 Safat, Kuwait
2
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kuwait University, PO Box 24923, 13110 Safat, Kuwait
3
Institute of Forensic Medicine, Department of Forensic Pharmacology and Toxicology, University of Zurich, 190/52 CH-8057 Zurich, Switzerland
4
School of Pharmacy, Institute for Pharmacology and Toxicology, The Philipps University of Marburg, Karl-von-Frisch-Straße, 135033 Marburg, Germany
The author wishes to make the following correction to this paper [1]. Due to mislabeling, replace: Ijms 21 03357 i001 with Ijms 21 03357 i002
There is an error in the peptide sequence of GIP in Figure 1. Two amino acid residues are missing. The correct sequence for GIP is: YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ. The authors would like to apologize for any inconvenience caused to the readers by these changes.

References

  1. Al-Zamel, N.; Al-Sabah, S.; Luqmani, Y.; Adi, L.; Chacko, S.; Schneider, T.D.; Krasel, C. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor. Int. J. Mol. Sci. 2019, 20, 3532. [Google Scholar] [CrossRef] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.